Clinical Trial Update: BRCA1/2 and Effect of Mifepristone on the Breast [Phase 2]

View source ↗

Summary

Phase 2 trial investigating mifepristone in women with BRCA1/2 mutations (breast cancer susceptibility).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Karolinska Institutet | Conditions: Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 | Phase 2 | Status: COMPLETED